tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
SNDX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSNDX Upcoming Earnings Report: What to Expect?
28d ago
Syndax price target raised to $28 from $27 at BofA
Premium
The Fly
Syndax price target raised to $28 from $27 at BofA
2M ago
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
Premium
Company Announcements
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
2M ago
Syndax reports preliminary Q4 Revuforj revenue $44M
PremiumThe FlySyndax reports preliminary Q4 Revuforj revenue $44M
2M ago
Syndax, WODA collaborate to launch program to expand access to Revuforj
Premium
The Fly
Syndax, WODA collaborate to launch program to expand access to Revuforj
3M ago
Syndax Pharmaceuticals Modernizes Bylaws for Electronic Share Issuance
Premium
Company Announcements
Syndax Pharmaceuticals Modernizes Bylaws for Electronic Share Issuance
3M ago
Syndax Pharmaceuticals: Q3 Earnings Call Highlights
PremiumCompany AnnouncementsSyndax Pharmaceuticals: Q3 Earnings Call Highlights
5M ago
Syndax price target raised to $38 from $35 at UBS
Premium
The Fly
Syndax price target raised to $38 from $35 at UBS
5M ago
Strong Growth Potential and Market Expansion Justify Buy Rating for Syndax Pharmaceuticals
Premium
Ratings
Strong Growth Potential and Market Expansion Justify Buy Rating for Syndax Pharmaceuticals
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100